Reconstruction of goat tibial defects using an injectable tricalcium phosphate/chitosan in combination with autologous platelet-rich plasma

Biomaterials

Volumn 31, Issue 12, 2010, Pages 3201-3211

  Bi, Long ^a   Cheng, Wenjun ^a   Fan, Hongbin ^a   Pei, Guoxian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone regeneration; Chitosan; Platelet rich plasma; Tricalcium phosphate

Indexed keywords

ADVERSE EFFECT; ALKALINE PHOSPHATASE ACTIVITY; BIOLOGICAL PROPERTIES; BONE DEFECT; BONE FORMATION; BONE REGENERATION; CELL COUNT; COLLAGEN TYPE I; GOAT MODEL; IN-CELL; MATURE BONE; MECHANICAL STRENGTH; OSTEOCALCIN; OSTEOINDUCTIVE PROPERTIES; PLATELET RICH PLASMA; RESIDUAL MATERIALS; REVERSE TRANSCRIPTASE- POLYMERASE CHAIN REACTION; TRI-CALCIUM PHOSPHATES;

BIOCOMPATIBILITY; BLOOD SUBSTITUTES; CALCIUM; CELL CULTURE; CHITIN; CHITOSAN; COMPRESSIVE STRENGTH; COOLING SYSTEMS; DEFECTS; FLOWCHARTING; GENE EXPRESSION; MECHANICAL PROPERTIES; PHOSPHATASES; PLASMAS; PLATELETS; PLATINUM COMPOUNDS; POLYMERASE CHAIN REACTION; POSITIVE TEMPERATURE COEFFICIENT; THERMAL CONDUCTIVITY;

BONE;

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; CHITOSAN; COLLAGEN TYPE 1; OSTEOCALCIN; OSTEONECTIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BONE DEFECT; BONE MINERALIZATION; BONE REGENERATION; CELL COUNT; CELL CULTURE; COMPRESSIVE STRENGTH; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GOAT; MALE; NONHUMAN; ORTHOPEDIC SURGERY; OSSIFICATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING;

ANIMALS; BASE SEQUENCE; BIOMECHANICS; CALCIUM PHOSPHATES; CELL PROLIFERATION; CHITOSAN; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA PRIMERS; GOATS; MICROSCOPY, ELECTRON, SCANNING; PLATELET-RICH PLASMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIBIA; TRANSFORMING GROWTH FACTOR BETA;

CAPRA HIRCUS;

EID: 76749088344     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.01.038     Document Type: Article

References (37)

1. Hofmann A., Ritz U., Verrier S., Eglin D., Alini M., Fuchs S., et al. The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. Biomaterials 29 (2008) 4217-4226
2. Tessmar J.K., and Göpferich A.M. Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Deliv Rev 59 (2007) 274-291
3. Yoshikawa H., Tamai N., Murase T., and Myoui A. Interconnected porous hydroxyapatite ceramics for bone tissue engineering. J R Soc Interface 6 (2009) S341-S348
4. Liu G., Zhao L., Zhang W., Cui L., Liu W., and Cao Y. Repair of goat tibial defects with bone marrow stromal cells and beta-tricalcium phosphate. J Mater Sci Mater Med 19 (2008) 2367-2376
5. Khan Y., Yaszemski M.J., Mikos A.G., and Laurencin C.T. Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am 90 (2008) S36-S42
6. Kretlow J.D., Klouda L., and Mikos A.G. Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 59 (2007) 263-273
7. Jayabalan M., Shalumon K.T., and Mitha M.K. Injectable biomaterials for minimally invasive orthopedic treatments. J Mater Sci Mater Med 20 (2009) 1379-1387
8. Bensaïd W., Triffitt J.T., Blanchat C., Oudina K., Sedel L., and Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24 (2003) 2497-2502
9. Liu H., Li H., Cheng W., Yang Y., Zhu M., and Zhou C. Novel injectable calcium phosphate/chitosan composites for bone substitute materials. Acta Biomater 2 (2006) 557-565
10. Petite H., Viateau V., Bensaïd W., Meunier A., de Pollak C., Bourguignon M., et al. Tissue-engineered bone regeneration. Nat Biotechnol 18 (2000) 959-963
11. Moreau J.L., and Xu H.H. Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan composite scaffold. Biomaterials 30 (2009) 2675-2682
12. Abarrategi A., Moreno-Vicente C., Ramos V., Aranaz I., Sanz Casado J.V., and López-Lacomba J.L. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application. Tissue Eng Part A 14 (2008) 1305-1319
13. Ohara N., Hayashi Y., Yamada S., Kim S.K., Matsunaga T., Yanagiguchi K., et al. Early gene expression analyzed by cDNA microarray and RT-PCR in osteoblasts cultured with water-soluble and low molecular chitooligosaccharide. Biomaterials 25 (2004) 1749-1754
14. Matsunaga T., Yanagiguchi K., Yamada S., Ohara N., Ikeda T., and Hayashi Y. Chitosan monomer promotes tissue regeneration on dental pulp wounds. J Biomed Mater Res A 76 (2006) 711-720
15. Lin L.C., Chang S.J., Kuo S.M., Chen S.F., and Kuo C.H. Evaluation of chitosan/beta-tricalcium phosphate microspheres as a constituent to PMMA cement. J Mater Sci Mater Med 16 (2005) 567-574
16. Lee J.Y., Seol Y.J., Kim K.H., Lee Y.M., Park Y.J., Rhyu I.C., et al. Transforming growth factor (TGF)-beta1 releasing tricalcium phosphate/chitosan microgranules as bone substitutes. Pharm Res 21 (2004) 1790-1796
17. Kasten P., Vogel J., Geiger F., Niemeyer P., Luginbühl R., and Szalay K. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29 (2008) 3983-3992
18. Bostrom M.P., Saleh K.J., and Einhorn T.A. Osteoinductive growth factors in preclinical fracture and long bone defects models. Orthop Clin North Am 30 (1999) 647-658
19. Kiuru J., Viinikka L., Myllyla G., Personen K., and Perheentupa J. Cytoskeleton-dependent release of human platelet epidermal growth factor. Life Sci 49 (1991) 1997-2003
20. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., and Georgeff K.R. Platelet rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 638-646
21. Kawase T., Okuda K., Wolff L.F., and Yoshie H. Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol 74 (2003) 858-864
22. Ishida K., Kuroda R., Miwa M., Tabata Y., Hokugo A., Kawamoto T., et al. The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng 13 (2007) 1103-1112
23. Laurencin C.T., Ambrosio A.M., Borden M.D., and Cooper Jr. J.A. Tissue engineering: orthopedic applications. Annu Rev Biomed Eng 1 (1999) 19-46
24. Gough J.E., Jones J.R., and Hench L.L. Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 25 (2004) 2039-2046
25. Ohsawa K., Neo M., Okamoto T., Tamura J., and Nakamura T. In vivo absorption of porous apatite- and wollastonite-containing glass-ceramic. J Mater Sci Mater Med 15 (2004) 859-864
26. Nair M.B., Varma H.K., and John A. Platelet-rich plasma and fibrin glue-coated bioactive ceramics enhance growth and differentiation of goat bone marrow-derived stem cells. Tissue Eng Part A 15 (2009) 1619-1631
27. Bertoldi C., Pinti M., Zaffe D., Cossarizza A., Consolo U., and Ceccherelli G.B. Morphologic, histochemical, and functional analysis of platelet-rich plasma activity on skeletal cultured cells. Transfusion (2009) [Epub ahead of print PMID: 19413738]
28. Froum S.J., Wallace S.S., Tarnow D.P., and Cho S.C. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent 22 (2002) 45-53
29. Aghaloo T.L., Moy P.K., and Freymiller E.G. Evaluation of platelet-rich plasma in combination with freeze-dried bone in the human cranium. A pilot study. Clin Oral Implants Res 16 (2005) 250-257
30. Carreon L.Y., Glassman S.D., Anekstein Y., and Puno R.M. Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine 30 (2005) E243-E246, [discussion E247]
31. Ranly D.M., Lohmann C.H., Andreacchio D., Boyan B.D., and Schwartz Z. Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am 89 (2007) 139-147
32. Marx R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62 (2004) 489-496
33. Marx R.E. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent 10 (2001) 225-228
34. Street J., and Lenehan B. Vascular endothelial growth factor regulates osteoblast survival - evidence for an autocrine feedback mechanism. J Orthop Surg Res 4 (2009) 19
35. Stein G.S., Lian J.B., Stein J.L., Van Wijnen A.J., and Montecino M. Transcriptional control of osteoblast growth and differentiation. Physiol Rev 76 (1996) 593-629
36. Delany A.M., and Canalis E. Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts. Am J Physiol 274 (1998) C734-C740
37. Dong J., Uemura T., Shirasaki Y., and Tateishi T. Promotion of bone formation using highly pure porous beta-TCP combined with bone marrow-derived osteoprogenitor cells. Biomaterials 23 (2002) 4493-4502